FTH · Faeth Therapeutics, Inc.
AI read · Neutral
The AI's read
The trial findings would show whether PIKTOR helped patients with advanced endometrial cancer. Without those findings, this filing does not show a change in Faeth's prospects.
Faeth Therapeutics shared a presentation about its Phase 2 trial results for a cancer treatment.
Neutral
Faeth shared a presentation about Phase 2 PIK-201, but this filing gives no trial findings. Without those results, the news does not change the company's outlook.
Get alerts for FTH
Follow Faeth Therapeutics, Inc. (FTH) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for FTHFree on the App Store and Google Play, or on the web.